FST and cancer: Collectively, the evidence surrounding FST in lung, ovarian, and HNSCC underscores the role of FST as an intermediary between tumor epithelial cells and the stroma, where it facilitates the aggressiveness of cancer cells, likely by fostering an immune-cold and drug-resistant TME.